147459-51-6,
cis-Octahydropyrrolo[3,4-b]pyridine,
(4aR,7aR)-octahydro-1H-pyrrolo[3,4-b]pyridine,
151213-42-2,
(R,R)-2,8-diazabicyclo[4,3,0]nonane,
(R,R)-2,8-Diazabicyclo[4.3.0]nonane,
CIS-OCTAHYDRO-1H-PYRROLO[3,4-B]PYRIDINE,
(4AR,7AR)-REL-OCTAHYDRO-1H-PYRROLO[3,4-B]PYRIDINE,
(S,S)-2,8-Diazabicyclo [4,3,0]nonane,
cis-Octahydro-pyrrolo[3,4-b]pyridine,
[R,R]-2,8-diazabicyclo[4.3.0]nonane,
1H-Pyrrolo[3,4-b]pyridine, octahydro-, (4aR,7aR)-,
MFCD09954739,
[R,R]-2,8-Diazabicyclo[4,3,0]nonane,
Octahydro-pyrrolo[3,4-b]pyridine,
AC1LTUYL,
PubChem11453,
1H-Pyrrolo[3,4-b]pyridine,octahydro-, (4aR,7aR)-rel-,
(R,R)-(+)-2,8-Diazabicyclo[4,3,0]nonane,
SCHEMBL606391,
CTK4C5419,
KS-00000EYW,
KS-00000IWP,
KSCPLKVBWDOSAI-RQJHMYQMSA-N,
ACT01802,
ANW-73829,
CD-019,
ZINC38339070,
AKOS006293924,
CS-W005708,
PB15781,
RP19715,
RTR-006198,
CIS-OCTAHYDROPYRROLO[3,4-B]PYR,
AK-50695,
BC677908,
BR-25446,
DS-10774,
SC-16157,
SC-93163,
AB0047799,
DB-008555,
DB-012877,
DB-027222,
ST2412742,
(1R,6R)-2,8-diazabicyclo[4,3,0]nonane,
(R, R)-2,8-diazabicyclo [4.3.0]nonane,
Z4175,
S-3629,
(4aR,7aR)-1H-octahydropyrrolo[3,4-b]pyridine,
(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridine,
213O422,
J-008789,
J-501358,
I14-32511,
I14-36176,
rel-(4aR,7aR)-Octahydro-1H-pyrrolo[3,4-b]pyridine,
(4aR,7aR)-2,3,4,4a,5,6,7,7a-octahydro-1H-pyrrolo[3,4-b]pyridine,
Moxifloxacin intermediate,
C7H14N2,
151213-40-0,
CB10684,
CID1515156,
(s,s)-2,8-diazabicyclo(4,3,0)nonane,
(S,S)-2,8-Diazabicyclo[4,3,0] nonane,
(S,S)-2,8-DIAZABICYCLO[4,3,0]NONANE,
A3219,
(S,S)-2,8-DIAZABICYCLO[4.3.0]NONANE,
(4aS,7aS)-Octahydro-1H-pyrrolo[3,4-b]pyridine,
AR-011/42531526,